EUVIMEDEUVIMED entdecken
Crossref

More treatment options emerge for EGFR ‐mutant NSCLC

Leah Lawrence

Cancer · 15.05.2026 · 132 (10)

DOI: 10.1002/cncr.70386 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, online erschienen am 16.05.2026. Verfasst von Leah Lawrence. Die Arbeit nennt 9 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This news section offers Cancer readers timely information on events, public policy analysis, and topical issues. In this issue, two recent studies continue to better personalize therapy for patients with EGFR‐mutated non‐small cell lung cancer. In addition, increased physical activity levels were associated with a reduction in cancer‐related fatigue and improved quality of life in patients with colorectal cancer, and early results support base‐edited anti‐CD7 CAR T‐cell therapy in T‐cell ALL.

Zitieren

APA

Lawrence, L. (2026). More treatment options emerge for EGFR ‐mutant NSCLC. Cancer, 132(10). https://doi.org/10.1002/cncr.70386

Vancouver

Lawrence L. More treatment options emerge for EGFR ‐mutant NSCLC. Cancer. 2026;132(10). doi:10.1002/cncr.70386

BibTeX
@article{Lawrence2026,
  author = {Lawrence, Leah},
  title = {More treatment options emerge for EGFR ‐mutant NSCLC},
  journal = {Cancer},
  year = {2026},
  volume = {132},
  number = {10},
  doi = {10.1002/cncr.70386}
}
Kostenlos starten →